Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hepatecellular Carcinoma × raltitrexed × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 7 Colorectal Neoplasms 7 Stomach Neoplasms 3 Colonic Neoplasms 3 Thrombocytopenia 1 Nasopharyngeal Carcinoma 1 Inoperable Esophageal Cancer Stage I-III 1 Hepatecellular Carcinoma 1 Fruquintinib 1 Esophageal Squamous Cell Carcinoma 1 Advanced Metastatic Colorectal Cancer 1 Advanced Gastric Cancer 1 Advanced Colorectal Carcinoma 1 Advanced Colorectal Cancer 1

Interventions

raltitrexed 1 Oxaliplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07327788 2026-01-13

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

Nanfang Hospital, Southern Medical University

Phase 2 Recruiting

Hepatecellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡